This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Robert I. Griffiths, ScD
Advertisement
Articles by Robert I. Griffiths, ScD
Advertisement
Latest Updated Articles
- Resource Use Among Nonvalvular Atrial Fibrillation Patients
Published: October 19th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
2
FDA Approves Reformulated Ranitidine After 5-Year Absence
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Updated Hypertension Guidelines Are Here
5
